N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)

C112H135N31O21S — CID 158316355

IUPACN-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)
SMILESC=S(N)(=O)c1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(N(C)C(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)C(C)(C)n2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.COc1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1OC
InChIInChI=1S/C20H25N5O3.C19H23N5O5.C19H23N5O3.C18H22N6O4S.2C18H21N5O3/c1-12(2)13-7-9-14(10-8-13)22-18(27)20(3,4)25-11-21-16-15(25)17(26)24(6)19(28)23(16)5;1-22-17-16(18(26)23(2)19(22)27)24(11-21-17)10-15(25)20-8-7-12-5-6-13(28-3)14(9-12)29-4;1-12(2)13-6-8-14(9-7-13)21(3)15(25)10-24-11-20-17-16(24)18(26)23(5)19(27)22(17)4;1-22-16-15(17(26)23(2)18(22)27)24(11-21-16)10-14(25)20-9-8-12-4-6-13(7-5-12)29(3,19)28;2*1-11(2)12-5-7-13(8-6-12)20-14(24)9-23-10-19-16-15(23)17(25)22(4)18(26)21(16)3/h7-12H,1-6H3,(H,22,27);5-6,9,11H,7-8,10H2,1-4H3,(H,20,25);6-9,11-12H,10H2,1-5H3;4-7,11H,3,8-10H2,1-2H3,(H2,19,28)(H,20,25);2*5-8,10-11H,9H2,1-4H3,(H,20,24)
InChIKeyGOHPHKQANRAYDP-UHFFFAOYSA-N
MW2283.57 g/mol
LogP4.09
Rot. Bonds29

About N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)

N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) (PubChem CID 158316355) has the molecular formula C112H135N31O21S and a molecular weight of 2283.57 g/mol. Its IUPAC name is N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide).

Molecular Properties

Compound NameN-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)
PubChem CID158316355
Molecular FormulaC112H135N31O21S
Molecular Weight2283.57 g/mol
Exact Mass2282.02
IUPAC NameN-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)
SMILESC=S(N)(=O)c1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(N(C)C(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)C(C)(C)n2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.COc1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1OC
InChIInChI=1S/C20H25N5O3.C19H23N5O5.C19H23N5O3.C18H22N6O4S.2C18H21N5O3/c1-12(2)13-7-9-14(10-8-13)22-18(27)20(3,4)25-11-21-16-15(25)17(26)24(6)19(28)23(16)5;1-22-17-16(18(26)23(2)19(22)27)24(11-21-17)10-15(25)20-8-7-12-5-6-13(28-3)14(9-12)29-4;1-12(2)13-6-8-14(9-7-13)21(3)15(25)10-24-11-20-17-16(24)18(26)23(5)19(27)22(17)4;1-22-16-15(17(26)23(2)18(22)27)24(11-21-16)10-14(25)20-9-8-12-4-6-13(7-5-12)29(3,19)28;2*1-11(2)12-5-7-13(8-6-12)20-14(24)9-23-10-19-16-15(23)17(25)22(4)18(26)21(16)3/h7-12H,1-6H3,(H,22,27);5-6,9,11H,7-8,10H2,1-4H3,(H,20,25);6-9,11-12H,10H2,1-5H3;4-7,11H,3,8-10H2,1-2H3,(H2,19,28)(H,20,25);2*5-8,10-11H,9H2,1-4H3,(H,20,24)
InChIKeyGOHPHKQANRAYDP-UHFFFAOYSA-N
XLogP4.09
TPSA598.28 Ų
H-Bond Donors6
H-Bond Acceptors45
Rotatable Bonds29
Heavy Atoms165
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002283.57
LogP ≤ 54.09
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)?
The IUPAC name of N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) (CID 158316355) is N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide).
What is the SMILES notation for N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)?
The canonical SMILES for N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) is C=S(N)(=O)c1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(N(C)C(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)C(C)(C)n2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.COc1ccc(CCNC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1OC.
What is the InChIKey of N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)?
The InChIKey is GOHPHKQANRAYDP-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H25N5O3.C19H23N5O5.C19H23N5O3.C18H22N6O4S.2C18H21N5O3/c1-12(2)13-7-9-14(10-8-13)22-18(27)20(3,4)25-11-21-16-15(25)17(26)24(6)19(28)23(16)5;1-22-17-16(18(26)23(2)19(22)27)24(11-21-17)10-15(25)20-8-7-12-5-6-13(28-3)14(9-12)29-4;1-12(2)13-6-8-14(9-7-13)21(3)15(25)10-24-11-20-17-16(24)18(26)23(5)19(27)22(17)4;1-22-16-15(17(26)23(2)18(22)27)24(11-21-16)10-14(25)20-9-8-12-4-6-13(7-5-12)29(3,19)28;2*1-11(2)12-5-7-13(8-6-12)20-14(24)9-23-10-19-16-15(23)17(25)22(4)18(26)21(16)3/h7-12H,1-6H3,(H,22,27);5-6,9,11H,7-8,10H2,1-4H3,(H,20,25);6-9,11-12H,10H2,1-5H3;4-7,11H,3,8-10H2,1-2H3,(H2,19,28)(H,20,25);2*5-8,10-11H,9H2,1-4H3,(H,20,24).
What are the key properties of N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide)?
N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) has a molecular weight of 2283.57 g/mol, XLogP of 4.09, 29 rotatable bonds, 6 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(amino-methylidene-oxo-λ6-sulfanyl)phenyl]ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-methyl-N-(4-propan-2-ylphenyl)acetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-2-methyl-N-(4-propan-2-ylphenyl)propanamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-propan-2-ylphenyl)acetamide) is sourced from PubChem (CID 158316355), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).